(Total Views: 1057)
Posted On: 05/19/2017 2:20:48 PM
Post# of 15624
Re: Specialneeds #8949
You are correct, the amounts and ratios are a red flag.
Take the annual report for this biotech stock that is trading in the same price range: EAR$ http://secfilings.nasdaq.com/filingFrameset.a...;View=html
EAR$ spent 5 times as much on R&D as it did on General expenses.
For a pre-clinical biotech, R&D spending should be through the roof.
Take the annual report for this biotech stock that is trading in the same price range: EAR$ http://secfilings.nasdaq.com/filingFrameset.a...;View=html
EAR$ spent 5 times as much on R&D as it did on General expenses.
For a pre-clinical biotech, R&D spending should be through the roof.
(1)
(3)
